|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Feo L, Polcino M and Nash GM: Resection of
the primary tumor in stage IV colorectal cancer: When is it
necessary? Surg Clin North Am. 97:657–669. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kuipers EJ, Grady WM, Lieberman D,
Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ and Watanabe T:
Colorectal cancer. Nat Rev Dis Primers. 1:150652015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gruber AD, Elble RC, Ji HL, Schreur KD,
Fuller CM and Pauli BU: Genomic cloning, molecular
characterization, and functional analysis of human CLCA1, the first
human member of the family of Ca2+-activated Cl-channel proteins.
Genomics. 54:200–214. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gandhi R, Elble RC, Gruber AD, Schreur KD,
Ji HL, Fuller CM and Pauli BU: Molecular and functional
characterization of a calcium-sensitive chloride channel from mouse
lung. J Biol Chem. 273:32096–32101. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pauli BU, Abdel-Ghany M, Cheng HC, Gruber
AD, Archibald HA and Elble RC: Molecular characteristics and
functional diversity of CLCA family members. Clin Exp Pharmacol
Physiol. 27:901–905. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Loewen ME and Forsyth GW: Structure and
function of CLCA proteins. Physiol Rev. 85:1061–1092. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Patel AC, Brett TJ and Holtzman MJ: The
role of CLCA proteins in inflammatory airway disease. Annu Rev
Physiol. 71:425–449. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li X, Hu W, Zhou J, Huang Y, Peng J, Yuan
Y, Yu J and Zheng S: CLCA1 suppresses colorectal cancer
aggressiveness via inhibition of the Wnt/beta-catenin signaling
pathway. Cell Commun Signal. 15:382017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang B, Cao L, Liu B, McCaig CD and Pu J:
The transition from proliferation to differentiation in colorectal
cancer is regulated by the calcium activated chloride channel A1.
PLoS One. 8:e608612013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gruber AD and Pauli BU: Tumorigenicity of
human breast cancer is associated with loss of the Ca2+-activated
chloride channel CLCA2. Cancer Res. 59:5488–5491. 1999.PubMed/NCBI
|
|
13
|
Sasaki Y, Koyama R, Maruyama R, Hirano T,
Tamura M, Sugisaka J, Suzuki H, Idogawa M, Shinomura Y and Tokino
T: CLCA2, a target of the p53 family, negatively regulates cancer
cell migration and invasion. Cancer Biol Ther. 13:1512–1521. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Agnel M, Vermat T and Culouscou JM:
Identification of three novel members of the calcium-dependent
chloride channel (CaCC) family predominantly expressed in the
digestive tract and trachea. FEBS Lett. 455:295–301. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu Y, Walia V and Elble RC: Loss of CLCA4
promotes epithelial-to-mesenchymal transition in breast cancer
cells. PLoS One. 8:e839432013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Carithers LJ, Ardlie K, Barcus M, Branton
PA, Britton A, Buia SA, Compton CC, DeLuca DS, Peter-Demchok J,
Gelfand ET, et al: A novel approach to high-quality postmortem
tissue procurement: The GTEx project. Biopreserv Biobank.
13:311–319. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shaul YD, Yuan B, Thiru P, Nutter-Upham A,
McCallum S, Lanzkron C, Bell GW and Sabatini DM: MERAV: A tool for
comparing gene expression across human tissues and cell types.
Nucleic Acids Res. 44(D1): D560–D566. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Warde-Farley D, Donaldson SL, Comes O,
Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT,
et al: The GeneMANIA prediction server: Biological network
integration for gene prioritization and predicting gene function.
Nucleic Acids Res 38 (Web Server Issue). W214–W220. 2010.
View Article : Google Scholar
|
|
19
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pardo LA and Stühmer W: The roles of K(+)
channels in cancer. Nat Rev Cancer. 14:39–48. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cuddapah VA and Sontheimer H: Ion channels
and transporters [corrected] in cancer. 2. Ion channels and the
control of cancer cell migration. Am J Physiol Cell Physiol.
301:C541–C549. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Peretti M, Angelini M, Savalli N, Florio
T, Yuspa SH and Mazzanti M: Chloride channels in cancer: Focus on
chloride intracellular channel 1 and 4 (CLIC1 AND CLIC4) proteins
in tumor development and as novel therapeutic targets. Biochim
Biophys Acta. 1848:2523–2531. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hoshino M, Morita S, Iwashita H, Sagiya Y,
Nagi T, Nakanishi A, Ashida Y, Nishimura O, Fujisawa Y and Fujino
M: Increased expression of the human Ca2+-activated Cl- channel 1
(CaCC1) gene in the asthmatic airway. Am J Respir Crit Care Med.
165:1132–1136. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim JA, Kang YS and Lee YS: Role of
Ca2+-activated Cl-channels in the mechanism of apoptosis induced by
cyclosporin A in a human hepatoma cell line. Biochem Biophys Res
Commun. 309:291–297. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Walia V, Ding M, Kumar S, Nie D, Premkumar
LS and Elble RC: hCLCA2 Is a p53-inducible inhibitor of breast
cancer cell proliferation. Cancer Res. 69:6624–6632. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bustin SA, Li SR and Dorudi S: Expression
of the Ca2+-activated chloride channel genes CLCA1 and CLCA2 is
downregulated in human colorectal cancer. DNA Cell Biol.
20:331–338. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pelaseyed T, Bergström JH, Gustafsson JK,
Ermund A, Birchenough GM, Schütte A, van der Post S, Svensson F,
Rodríguez-Piñeiro AM, Nyström EE, et al: The mucus and mucins of
the goblet cells and enterocytes provide the first defense line of
the gastrointestinal tract and interact with the immune system.
Immunol Rev. 260:8–20. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nyström EEL, Birchenough GMH, van der Post
S, Arike L, Gruber AD, Hansson GC and Johansson MEV:
Calcium-activated chloride channel regulator 1 (CLCA1) controls
mucus expansion in colon by proteolytic activity. EBioMedicine.
33:134–143. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang B, Cao L, Liu J, Xu Y, Milne G, Chan
W, Heys SD, McCaig CD and Pu J: Low expression of chloride channel
accessory 1 predicts a poor prognosis in colorectal cancer. Cancer.
121:1570–1580. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ramena G, Yin Y, Yu Y, Walia V and Elble
RC: CLCA2 interactor EVA1 is required for mammary epithelial cell
differentiation. PLoS One. 11:e01474892016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sharma A, Ramena G, Yin Y, Premkumar L and
Elble RC: CLCA2 is a positive regulator of store-operated calcium
entry and TMEM16A. PLoS One. 13:e01965122018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kruse JP and Gu W: Modes of p53
regulation. Cell. 137:609–622. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tanikawa C, Nakagawa H, Furukawa Y,
Nakamura Y and Matsuda K: CLCA2 as a p53-inducible senescence
mediator. Neoplasia. 14:141–149. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Herr HW and Donat SM: Prostatic tumor
relapse in patients with superficial bladder tumors: 15-year
outcome. J Urol. 161:1854–1857. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lu CY, Uen YH, Tsai HL, Chuang SC, Hou MF,
Wu DC, Juo SH, Lin SR and Wang JY: Molecular detection of
persistent postoperative circulating tumour cells in stages II and
III colon cancer patients via multiple blood sampling: Prognostic
significance of detection for early relapse. Br J Cancer.
104:1178–1184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Barrier A, Lemoine A, Boelle PY, Tse C,
Brault D, Chiappini F, Breittschneider J, Lacaine F, Houry S,
Huguier M, et al: Colon cancer prognosis prediction by gene
expression profiling. Oncogene. 24:6155–6164. 2005. View Article : Google Scholar : PubMed/NCBI
|
